Marcel Konrad

Medexus Pharmaceuticals, Inc.

Marcel Konrad joined Medexus in 2021 from CareDx, Inc. (Nasdaq: CDNA), a precision medicine solutions company, where he served as Senior Vice President Finance & Accounting and Vice President, Corporate Controller. Mr. Konrad brings over 20 years of experience in Accounting, Finance and Business across various global markets that include Chief Financial Officer at Santen Inc, a US subsidiary of Santen Pharmaceuticals, a Japanese eye care company and various roles at Novartis both in the US and Switzerland. Mr. Konrad was an Auditor with KPMG. He holds an International MBA from the University of San Diego and has a Masters of Business Administration from HEC Lausanne, Switzerland. Mr. Konrad is an active US CPA.